David J. Main

2017

In 2017, David J. Main earned a total compensation of $3M as Chief Executive Officer and President at Aquinox Pharmaceuticals, a 131% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$240,975
Option Awards$2,289,339
Salary$510,000
Total$3,040,314

Main received $2.3M in option awards, accounting for 75% of the total pay in 2017.

Main also received $241K in non-equity incentive plan and $510K in salary.

Rankings

In 2017, David J. Main's compensation ranked 3,584th out of 14,666 executives tracked by ExecPay. In other words, Main earned more than 75.6% of executives.

ClassificationRankingPercentile
All
3,584
out of 14,666
76th
Division
Manufacturing
1,237
out of 5,772
79th
Major group
Chemicals And Allied Products
346
out of 2,075
83rd
Industry group
Drugs
267
out of 1,731
85th
Industry
Pharmaceutical Preparations
211
out of 1,333
84th
Source: SEC filing on March 26, 2018.

Main's colleagues

We found two more compensation records of executives who worked with David J. Main at Aquinox Pharmaceuticals in 2017.

2017

Abigail Jenkins

Aquinox Pharmaceuticals

Chief Commercial Officer and U.S. Business Head

2017

Kamran Alam

Aquinox Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like